triazoles has been researched along with Heart Failure in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (16.00) | 29.6817 |
| 2010's | 19 (76.00) | 24.3611 |
| 2020's | 1 (4.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alexanian, M; Bagchi, RA; Cavasin, MA; Enyart, BY; Felisbino, MB; Haldar, SM; Hirsch, RA; Koch, KA; Lam, MPY; Lemieux, ME; Lin, CY; McKinsey, TA; Qi, J; Riching, AS; Smith, HE; Song, K; Srivastava, D; Stratton, MS | 1 |
| Foster, DB; Jones, JW; Kane, MA; Liu, T; Margulies, KB; O'Rourke, B; Papanicolaou, KN; Parker, LE; Talbot, CC; Yang, N; Yu, J | 1 |
| Anand, P; Bradner, JE; Brown, JD; Duan, Q; Haldar, SM; Huang, Y; Lemieux, ME; McKinsey, TA; McMahon, S; Sahadevan, A; Salunga, HT; Shah, H; Srivastava, D; Thomas, S; Zhang, R | 1 |
| Ummarino, D | 1 |
| Aramaki, Y; Fukumoto, S; Hata, A; Henta, T; Hoffman, ID; Ikeda, S; Kaneko, M; Kawamoto, T; Kobayashi, T; Okawa, T; Sang, BC; Toyoda, Y; Yamamoto, M; Zou, H | 1 |
| Greene, M; Harris, B; Kuriakose, K; Nesbitt, WJ | 1 |
| Akihiro, S; Daida, H; Fujibayashi, K; Kasai, T; Matsumoto, H; Nishizaki, Y; Nojiri, S; Ogita, M; Ono, N; Shitara, J; Suda, S; Suwa, S; Yanagisawa, N; Yatsu, S | 1 |
| Antonio, EL; Arruda-Junior, DF; Barreto, AL; Campos, LC; dos Santos, L; Girardi, AC; Krieger, JE; Mansur, AJ; Pereira, AC; Salles, TA; Tucci, PJ | 1 |
| Bina, P; Cossa, S; Danjou, F; Defraia, E; Dessì, C; Foschini, ML; Galanello, R; Leoni, G; Matta, G; Morittu, M; Origa, R | 1 |
| Dorazilova, Z; Maly, J; Netuka, I; Pirk, J; Szarszoi, O | 1 |
| Eurich, DT; McAlister, FA; Minhas-Sandhu, JK; Senthilselvan, A; Weir, DL | 1 |
| Bhatt, DL; Cavender, MA | 1 |
| Chao, TF; Chen, SJ; Chen, TJ; Chiang, CE; Huang, CM; Lin, SJ; Liu, CJ; Wang, KL; Wu, CH; Yeh, CM | 1 |
| Armstrong, PW; Bethel, MA; Buse, JB; Engel, SS; Garg, J; Green, JB; Holman, RR; Josse, R; Kaufman, KD; Koglin, J; Korn, S; Lachin, JM; McGuire, DK; Pencina, MJ; Peterson, ED; Standl, E; Stein, PP; Suryawanshi, S; Van de Werf, F | 1 |
| Abdullah, T; Baggio, LL; Bang, KW; Campbell, JE; Drucker, DJ; Mulvihill, EE; Ussher, JR; Varin, EM | 1 |
| Belardinelli, L; Chi, L; Dhalla, AK; Hirakawa, R; Ling, H; Rajamani, S; Zeng, A | 1 |
| Bearman, G; Pakyz, A | 1 |
| Aydinok, Y; Cappellini, MD; Chan, LL; Domokos, G; El-Beshlawy, A; Elalfy, MS; Habr, D; Ibrahim, H; Kattamis, A; Li, CK; Pennell, DJ; Porter, JB; Roubert, B; Smith, G; Sutcharitchan, P; Taher, A; Viprakasit, V | 1 |
| Baerts, L; Bartunek, J; De Meester, I; Gomez, N; Lybaert, P; Mahmoudabady, M; Matheeussen, V; Mathieu, M; Mc Entee, K; Mendes Da Costa, A; Peace, A; Scharpé, S; Touihri, K; Vanderheyden, M | 1 |
| Brevi, F; Cappellini, MD; Cassinerio, E; Graziadei, G; Milazzo, A; Pattoneri, P; Pedrotti, P; Roghi, A; Zanaboni, L | 1 |
| Ackermann, F; Charles, P; Honderlick, P; Kahn, JE; Lortholary, O | 1 |
| Abbracchio, MP; Borea, PA; Camurri, A; Capecchi, PL; Cattabeni, F; Ceccatelli, L; Diciolla, F; Laghi-Pasini, F; Lazzerini, PE; Maccherini, M; Ulouglu, C; Varani, K | 1 |
| HUSTON, JR; OSER, BM; RYAN, JM | 1 |
| Calderone, A; Frasure-Smith, N; Lafontaine, S; Laliberté, MA; Lespérance, F; Rouleau, JL; Talajic, M; White, M | 1 |
| Abbracchio, MP; Camurri, A; Capecchi, PL; Diciolla, F; Laghi-Pasini, F; Lazzerini, PE; Maccherini, M; Mazzola, A; Pompella, G | 1 |
2 review(s) available for triazoles and Heart Failure
| Article | Year |
|---|---|
Heart failure: BRD4 inhibition slows HF progression.
Topics: Animals; Azepines; Cell Cycle Proteins; Disease Progression; Heart Failure; Humans; Nuclear Proteins; Transcription Factors; Triazoles | 2017 |
Fungal infections associated with long-term mechanical circulatory support-diagnosis and management.
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Fluconazole; Heart Failure; Heart-Assist Devices; Humans; Incidence; Mycoses; Pyrimidines; Risk Factors; Time Factors; Triazoles; Voriconazole | 2014 |
5 trial(s) available for triazoles and Heart Failure
| Article | Year |
|---|---|
Effects of suvorexant on sleep apnea in patients with heart failure: A protocol of crossover pilot trial.
Topics: Azepines; Cross-Over Studies; Equivalence Trials as Topic; Female; Heart Failure; Humans; Male; Middle Aged; Pilot Projects; Polysomnography; Randomized Controlled Trials as Topic; Sleep; Sleep Aids, Pharmaceutical; Sleep Apnea Syndromes; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Triazoles | 2019 |
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes.
Topics: Administration, Oral; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Follow-Up Studies; Glycated Hemoglobin; Heart Diseases; Heart Failure; Hospitalization; Humans; Hypoglycemic Agents; Kaplan-Meier Estimate; Pyrazines; Sitagliptin Phosphate; Triazoles | 2015 |
Efficacy of deferasirox in reducing and preventing cardiac iron overload in beta-thalassemia.
Topics: Adolescent; Adult; Benzoates; beta-Thalassemia; Child; Deferasirox; Dose-Response Relationship, Drug; Female; Ferritins; Heart Failure; Humans; Iron; Iron Chelating Agents; Iron Overload; Male; Myocardium; Prospective Studies; Triazoles; Young Adult | 2010 |
Cardiac iron removal and functional cardiac improvement by different iron chelation regimens in thalassemia major patients.
Topics: Adult; Benzoates; beta-Thalassemia; Comorbidity; Deferasirox; Deferiprone; Deferoxamine; Drug Therapy, Combination; Female; Follow-Up Studies; Heart; Heart Failure; Humans; Iron Chelating Agents; Male; Myocardium; Patient Compliance; Prospective Studies; Pyridones; Stroke Volume; Triazoles; Young Adult | 2012 |
An open-label study of nefazodone treatment of major depression in patients with congestive heart failure.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Tolerance; Electrocardiography; Electrocardiography, Ambulatory; Feasibility Studies; Female; Follow-Up Studies; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Norepinephrine; Piperazines; Severity of Illness Index; Surveys and Questionnaires; Triazoles | 2003 |
18 other study(ies) available for triazoles and Heart Failure
| Article | Year |
|---|---|
Dynamic Chromatin Targeting of BRD4 Stimulates Cardiac Fibroblast Activation.
Topics: Animals; Azepines; Cell Adhesion Molecules; Cells, Cultured; Chromatin; Enhancer Elements, Genetic; Epigenesis, Genetic; Extracellular Matrix; Female; Fibrosis; Heart Failure; Heart Ventricles; Intracellular Signaling Peptides and Proteins; Male; Mice; Mice, Inbred C57BL; Myofibroblasts; Nuclear Proteins; p38 Mitogen-Activated Protein Kinases; Protein Binding; Rats; Rats, Sprague-Dawley; RNA Polymerase II; Transcription Factors; Transcriptome; Transforming Growth Factor beta; Triazoles | 2019 |
Cardiac retinoic acid levels decline in heart failure.
Topics: Adult; Aged; Animals; Animals, Newborn; Benzothiazoles; Cardiomyopathy, Dilated; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P450 Family 26; Female; Gene Expression Regulation; Guinea Pigs; Heart Failure; Heart Ventricles; Humans; Male; Middle Aged; Myocardium; Myocytes, Cardiac; Rats; Tretinoin; Triazoles; Ventricular Remodeling; Vitamin A; Young Adult | 2021 |
BET bromodomain inhibition suppresses innate inflammatory and profibrotic transcriptional networks in heart failure.
Topics: Animals; Azepines; Cardiomegaly; Gene Regulatory Networks; Heart Failure; Humans; Induced Pluripotent Stem Cells; Inflammation; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; NF-kappa B; Proteins; Signal Transduction; Transforming Growth Factor beta; Triazoles | 2017 |
Design, Synthesis, and Evaluation of the Highly Selective and Potent G-Protein-Coupled Receptor Kinase 2 (GRK2) Inhibitor for the Potential Treatment of Heart Failure.
Topics: Crystallography, X-Ray; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Design; G-Protein-Coupled Receptor Kinase 2; Heart Failure; HEK293 Cells; High-Throughput Screening Assays; Humans; Hydrazones; meta-Aminobenzoates; Protein Kinase C-alpha; Protein Kinase Inhibitors; Pyridines; Receptors, Adrenergic, beta; rho-Associated Kinases; Structure-Activity Relationship; Triazoles | 2017 |
Posaconazole-Induced Pseudohyperaldosteronism.
Topics: Aged; Antifungal Agents; Heart Failure; Histoplasmosis; Humans; Hydroxysteroid Dehydrogenases; Hyperaldosteronism; Hypertension; Hypokalemia; Mineralocorticoid Excess Syndrome, Apparent; Triazoles; Voriconazole | 2018 |
Circulating dipeptidyl peptidase IV activity correlates with cardiac dysfunction in human and experimental heart failure.
Topics: Adult; Aged; Animals; Apoptosis; Biomarkers; Case-Control Studies; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Female; Glucagon-Like Peptide 1; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardium; Natriuretic Peptide, Brain; Pulmonary Edema; Pyrazines; Rats; Rats, Wistar; Sitagliptin Phosphate; Triazoles; Up-Regulation; Ventricular Function, Left; Ventricular Remodeling | 2013 |
Impact of heart magnetic resonance imaging on chelation choices, compliance with treatment and risk of heart disease in patients with thalassaemia major.
Topics: Adult; Area Under Curve; Arrhythmias, Cardiac; Benzoates; beta-Thalassemia; Chelation Therapy; Deferasirox; Deferiprone; Deferoxamine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Heart Failure; Humans; Iron; Iron Chelating Agents; Iron Overload; Magnetic Resonance Imaging; Male; Myocardium; Patient Compliance; Predictive Value of Tests; Pyridones; Risk; ROC Curve; Sampling Studies; Transfusion Reaction; Triazoles; Young Adult | 2013 |
Sitagliptin use in patients with diabetes and heart failure: a population-based retrospective cohort study.
Topics: Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dipeptidyl-Peptidase IV Inhibitors; Female; Heart Failure; Hospitalization; Humans; Male; Middle Aged; Pyrazines; Retrospective Studies; Risk Factors; Sitagliptin Phosphate; Treatment Outcome; Triazoles | 2014 |
Do dipeptidyl peptidase-4 inhibitors increase the risk of heart failure?
Topics: Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dipeptidyl-Peptidase IV Inhibitors; Female; Heart Failure; Humans; Male; Pyrazines; Triazoles | 2014 |
Sitagliptin and the risk of hospitalization for heart failure: a population-based study.
Topics: Diabetes Mellitus; Female; Follow-Up Studies; Glucagon-Like Peptide 1; Heart Failure; Hospitalization; Humans; Hypoglycemic Agents; Male; Middle Aged; Morbidity; Population Surveillance; Propensity Score; Pyrazines; Retrospective Studies; Risk Assessment; Risk Factors; Sitagliptin Phosphate; Taiwan; Triazoles | 2014 |
Inhibition of Dipeptidyl Peptidase-4 Impairs Ventricular Function and Promotes Cardiac Fibrosis in High Fat-Fed Diabetic Mice.
Topics: Animals; Cardiomegaly; Cytokines; Diabetes Mellitus, Experimental; Diet, High-Fat; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Fibrosis; Heart; Heart Failure; Hypoglycemic Agents; Immunoblotting; Inflammation; Liraglutide; Mice; Mice, Knockout; Myocardium; RNA, Messenger; Transcriptome; Triazoles; Ventricular Function; Ventricular Remodeling | 2016 |
Inhibition of late Na+ current, a novel target to improve diastolic function and electrical abnormalities in Dahl salt-sensitive rats.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disease Models, Animal; Dose-Response Relationship, Drug; Heart Conduction System; Heart Failure; Heart Rate; Hypertrophy, Left Ventricular; Male; Myocardial Contraction; Myocytes, Cardiac; Oxidative Stress; Pyridines; Rats, Inbred Dahl; Sodium Channel Blockers; Sodium Channels; Sodium Chloride, Dietary; Time Factors; Triazoles; Ventricular Dysfunction, Left; Ventricular Function, Left | 2016 |
Adverse drug events complicate antifungal therapy for pulmonary aspergilloma.
Topics: Aged; Antifungal Agents; Aspergillosis; Drug Interactions; Follow-Up Studies; Hallucinations; Heart Failure; Humans; Itraconazole; Liver Function Tests; Lung Diseases, Fungal; Male; Pyrimidines; Triazoles; Voriconazole | 2008 |
Dipeptidyl peptidase IV inhibition improves cardiorenal function in overpacing-induced heart failure.
Topics: Animals; Calmodulin; Cardiac Pacing, Artificial; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Female; Glomerular Filtration Rate; Heart Failure; Heart Rate; Hemodynamics; Interleukin-6; Natriuretic Peptide, Brain; Pyrazines; Sitagliptin Phosphate; Sodium-Calcium Exchanger; Swine; Triazoles | 2012 |
Renal mucormycosis complicating extracorporeal membrane oxygenation.
Topics: Acute Kidney Injury; Aged; Amphotericin B; Antifungal Agents; Cross Infection; Extracorporeal Membrane Oxygenation; Female; France; Heart Failure; Humans; Immunocompromised Host; Kidney; Mucormycosis; Rheumatic Fever; Rhizopus; Treatment Outcome; Triazoles; Tuberculosis, Pulmonary | 2013 |
Changes of peripheral A2A adenosine receptors in chronic heart failure and cardiac transplantation.
Topics: Binding, Competitive; Female; Heart Failure; Heart Transplantation; Humans; Kinetics; Lymphocytes; Male; Myocardium; Neutrophils; Receptor, Adenosine A2A; Receptors, Purinergic P1; Triazines; Triazoles; Tritium | 2003 |
The effect of tilting on the right atrial pressure of patients with heart failure.
Topics: Atrial Pressure; Blood Pressure; Blood Pressure Determination; Heart Failure; Humans; Triazoles | 1958 |
Upregulation of A2A adenosine receptor expression by TNF-alpha in PBMC of patients with CHF: a regulatory mechanism of inflammation.
Topics: Adenosine; Blotting, Western; Female; Heart Failure; Humans; Lipopolysaccharides; Male; Middle Aged; Neutrophils; Phenethylamines; Receptor, Adenosine A2A; Receptors, Purinergic P1; Reverse Transcriptase Polymerase Chain Reaction; Triazines; Triazoles; Tumor Necrosis Factor-alpha; Up-Regulation | 2005 |